1. Home
  2. NDLS vs UBX Comparison

NDLS vs UBX Comparison

Compare NDLS & UBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDLS
  • UBX
  • Stock Information
  • Founded
  • NDLS 1995
  • UBX 2009
  • Country
  • NDLS United States
  • UBX United States
  • Employees
  • NDLS N/A
  • UBX N/A
  • Industry
  • NDLS Restaurants
  • UBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NDLS Consumer Discretionary
  • UBX Health Care
  • Exchange
  • NDLS Nasdaq
  • UBX Nasdaq
  • Market Cap
  • NDLS 34.3M
  • UBX 38.6M
  • IPO Year
  • NDLS 2013
  • UBX 2018
  • Fundamental
  • Price
  • NDLS $1.50
  • UBX $2.10
  • Analyst Decision
  • NDLS Strong Buy
  • UBX Strong Buy
  • Analyst Count
  • NDLS 2
  • UBX 2
  • Target Price
  • NDLS $3.00
  • UBX $7.00
  • AVG Volume (30 Days)
  • NDLS 355.5K
  • UBX 369.6K
  • Earning Date
  • NDLS 03-06-2025
  • UBX 11-04-2024
  • Dividend Yield
  • NDLS N/A
  • UBX N/A
  • EPS Growth
  • NDLS N/A
  • UBX N/A
  • EPS
  • NDLS N/A
  • UBX N/A
  • Revenue
  • NDLS $495,817,000.00
  • UBX N/A
  • Revenue This Year
  • NDLS $0.24
  • UBX N/A
  • Revenue Next Year
  • NDLS $0.19
  • UBX $33.62
  • P/E Ratio
  • NDLS N/A
  • UBX N/A
  • Revenue Growth
  • NDLS N/A
  • UBX N/A
  • 52 Week Low
  • NDLS $0.55
  • UBX $0.94
  • 52 Week High
  • NDLS $2.68
  • UBX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • NDLS 68.95
  • UBX 62.50
  • Support Level
  • NDLS $1.30
  • UBX $2.05
  • Resistance Level
  • NDLS $1.73
  • UBX $2.42
  • Average True Range (ATR)
  • NDLS 0.17
  • UBX 0.31
  • MACD
  • NDLS 0.02
  • UBX -0.01
  • Stochastic Oscillator
  • NDLS 73.26
  • UBX 41.67

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

Share on Social Networks: